Profound Medical Q3 Revenue Rises 86% to $9.8 Million
Profound Medical reported third-quarter 2026 gross margin of 78% and a net loss of $7.7 million, or $0.21 per share. Cash used in operating activities declined 56% sequentially to $5.0 million. The company expects full-year revenue of at least…
Profound Medical reported third-quarter 2026 revenue of $9.8 million, up 86% year over year, and gross margin of 78%. Net loss was $7.7 million, or $0.21 per share, while cash used in operating activities declined 56% sequentially to $5.0 million. The company expects full-year revenue of at least…